Reply to Comment on “Artificial intelligence-guided end point selection for neuroprotection trials in glaucoma”

American Journal of Ophthalmology 2026

View at publisher

Authors: Douglas R. da Costa, Felipe Andrade Medeiros

DOI: 10.1016/j.ajo.2026.03.002

Cited by: 0

References: 1

Fields of Study & Subjects

Glaucoma and retinal disorders Statistical Methods in Clinical Trials Statistical Methods in Epidemiology

References 1